Our engineering team has developed patent-pending technologies for superior product performance in a wide range of clinical applications.
By using proprietary computer vision, design innovations and advanced engineering, we produce the highest quality devices on the market with enhanced clinical and functional capabilities designed to deliver outstanding surgical performance.
Our cutting-edge manufacturing facility based in Massachusetts, USA utilizes advanced automation technologies to drive superior quality and cost efficiency.
Founder and CEO
Leon is the founder and CEO of the company. Previously, he co-founded and ran Rhythmia Medical, Inc, which developed a revolutionary cardiac mapping system for the treatment of cardiac arrhythmias, and was acquired by Boston Scientific in 2012. The technology has been used to help treat over 25,000 patients across several hundreds of hospitals around the world.
Prior to Rhythmia, Leon led business development at Ceragon Networks Ltd (Nasdaq: CRNT), and worked at Deutsche Bank Alex Brown. Leon holds an MBA degree from Harvard Business School and a Masters of Engineering degree from the University of Cambridge. Leon speaks 6 languages and holds close to 30 issued and pending medical device patents.
Marc leads Operations at Lexington Medical as an Executive VP. He was previously CEO of innoPad, a materials technology company that developed and manufactured precision equipment for semiconductor manufacturing, and was acquired by FNS Tech in 2013. Prior to that, Marc led the production launch of multiple engines programs at Ford. Marc graduated with an MBA from MIT Sloan and a BSME from Cornell University.
Luke Dohmen acts as Lexington Medical's Chief Patent Counsel. Luke has over 25 years of Intellectual Property legal experience in the medical device field. He was previously Chief Patent Counsel for Boston Scientific Corp for where he spent 23 years leading the worldwide IP team. He provides advice on intellectual property related issues.
Doron serves as a Board Member of Lexington Medical, and is the founder and CEO of Affera, Inc. Previously, he co-founded and ran Rhythmia Medical with Leon. Post the acquisition of the company Doron served as Vice President of Product and Technology at Boston Scientific. Doron is a prolific inventor holding over 90 issued and pending patents.
Phil serves as a Board Member at Lexington Medical. He has designed, built and brought numerous medical technologies to market and uses that expertise at Norwich Ventures to assess and assist entrepreneurs with building their companies. Phil was also on the board of Rhythmia Medical. Previously, Phil was the President/COO of Arrow International, with oversight of worldwide R&D and manufacturing.
Shawn is VP of Sales at Lexington Medical, responsible for sales and business development in the United States. Shawn brings 25 years of sales and sales management experience, with a long and demonstrated history of success working in the Medical Device industry. Previously, Shawn was the Global VP of Sales at Mederi Therapeutics, and has held sales and sales management positions with Xerox Healthcare, Perot Systems and Cerner Corporation.
Andrew is the Director of Technology at Lexington Medical, leading the engineering design and development of Lexington Medical’s surgical devices, including the AEON™ Endostapler. Previously, he was a mechanical design engineer for Rhythmia Medical, and then worked with Boston Scientific after the Rhythmia's acquisition. Andrew graduated from MIT with a BS and MS in mechanical engineering.
Dr. Daniel Herron
Dr. Herron is the Chief of Laparoscopic and Bariatric Surgery at Icahn School of Medicine at Mount Sinai, New York. Dr. Herron has been performing laparoscopic bariatric surgery since joining the Mount Sinai Faculty in 1999. Dr. Herron completed his undergraduate education at Harvard College and obtained his medical degree at the University of Pennsylvania School of Medicine. He sits on the Board of Governors of SAGES.
Dr. Andrew Duffy
Dr. Duffy is a Board Certified General Surgeon and is fellowship-trained in minimal access surgery. He is the Director of Bariatric and Metabolic Surgery for the Yale-New Haven Health System and Associate Professor of Surgery at Yale School of Medicine. He received his medical degree from University of Massachusetts Medical School and his fellowship at Weill Medical College of Cornell University.
Dr. Natan Zundel
Dr. Zundel is an internationally recognized thought leader, professor, trainer, and innovator in the field of Minimally Invasive and Metabolic and Bariatric Surgery, with over 24 national and international awards for research in the field. He is a past President of IFSO, member of the Executive Council of ASMBS and Board of Governors at SAGES. He currently serves as a Clinical Professor of Surgery and the Vice-Chairman of the Department of Surgery at Florida International University’s Herbert Wertheim College of Medicine.